Home > Insider Trading > Filing (0001209191-12-036317)

Filing Details

Accession Number:: 0001209191-12-036317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-02 19:19:56
Reporting Period:: 2012-06-28

Filing Date:: 2012-07-02
Accepted Time:: 2012-07-02 18:19:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
754813	Healthwarehouse.com Inc.	HEWA	Retail-Drug Stores And Proprietary Stores (5912)	222413505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
949119	Iii I Lloyd Miller	222 Lakeview Avenue Suite 160-365 West Palm Beach FL 33401		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-28	156,250	$1.60	156,250	No	4	X	Indirect	By Milfam I L.P.
Common Stock	Acquisiton	2012-06-28	156,250	$1.60	312,500	No	4	X	Indirect	By Milfam I L.P.
Common Stock	Acquisiton	2012-06-28	585,808	$3.00	898,308	No	4	X	Indirect	By Milfam I L.P.
Common Stock	Acquisiton	2012-06-28	250,000	$2.90	1,148,308	No	4	X	Indirect	By Milfam I L.P.
Common Stock	Disposition	2012-06-28	38,343	$6.74	1,109,965	No	4	S	Indirect	By Milfam I L.P.
Common Stock	Disposition	2012-06-28	38,343	$6.74	1,071,622	No	4	S	Indirect	By Milfam I L.P.
Common Stock	Disposition	2012-06-28	251,419	$6.99	820,203	No	4	S	Indirect	By Milfam I L.P.
Common Stock	Disposition	2012-06-28	103,719	$6.99	716,484	No	4	S	Indirect	By Milfam I L.P

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	By Milfam I L.P.
No	4	X	Indirect	By Milfam I L.P.
No	4	X	Indirect	By Milfam I L.P.
No	4	X	Indirect	By Milfam I L.P.
No	4	S	Indirect	By Milfam I L.P.
No	4	S	Indirect	By Milfam I L.P.
No	4	S	Indirect	By Milfam I L.P.
No	4	S	Indirect	By Milfam I L.P

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Disposition	2012-06-28	250,000	$0.00	250,000	$2.90
Common Stock	Warrant	Disposition	2012-06-28	156,250	$0.00	156,250	$1.60
Common Stock	Warrant	Disposition	2012-06-28	156,250	$0.00	156,250	$1.60
Common Stock	Warrant	Disposition	2012-06-28	585,808	$0.00	585,808	$3.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2011-09-02	2016-09-02	No	4	X	Indirect
2009-12-15	2014-12-15	No	4	X	Indirect
2010-05-03	2015-05-03	No	4	X	Indirect
2010-11-08	2015-11-08	No	4	X	Indirect

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Series B Preferred Stock	$0.00	2010-11-08		886,895	886,895	Indirect
Common Stock	7% Senior Secured Convertible Promissory Note	$0.00	2010-11-08	2012-12-31	292,620	292,620	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	886,895	886,895	Indirect
2012-12-31	292,620	292,620	Indirect

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securites covered by this filing.
The reporting person exercised a warrant to purchase 156,250 shares of common stock for the original conversion price of $1.60 per share. The reporting person paid the exercise price on a cashless basis, resulting in the company issuing 117,907 shares of common stock to the reporting person.
The reporting person exercised a warrant to purchase 585,808 shares of common stock for the original conversion price of $3.00 per share. The reporting person paid the exercise price on a cashless basis, resulting in the company issuing 334,389 shares of common stock to the reporting person.
The reporting person exercised a warrant to purchase 250,000 shares of common stock for the original conversion price of $2.90 per share. The reporting person paid the exercise price on a cashless basis, resulting in the company issuing 146,281 shares of common stock to the reporting person.
The reporting person holds 177,379 shares of Series B Preferred Stock. This amount includes 11,605 shares of Series B Preferred Stock received by the reporting person as a dividend for the year 2011. Each share of Series B Preferrred Stock is immediately convertible into 5 shares of common stock.
N/A
The convertible note is immediately convertible into 58,524 shares of Series B Preferred Stock which amount includes a $53,048.39 interest payment on the convertible note received through May 8, 2012. Each share of Series B Preferred Stock is immediately convertible into 5 shares of common stock.